Serologic diagnosis of West Nile virus infection

References

• Lindenbach BD, Rice CM. Flaviviridae: the virus and their replication. In: Fields Virology 4th Edition. Knipe DM, Howley PM (Eds), Lippincott William & Wilkins, PA, USA, 991–1042 (2001).
   Google Scholar
• Burke DS, Monath TR Flaviviruses. In: Fields Vimlogy 4th Edition. Knipe DM, Howley PM (Eds). Lippincott William & Wilkins, PA, USA, 1043–1126 (2001).
   Google Scholar
• Chambers TJ, Hahn CS, Galler R etal Ravivirus genome organization, expression and replication. Ann. Rev IVlicmbiol. 44, 649–688 (1990).
   Google Scholar
• Brinton MA. The molecular biology of West Nile virus: a new invader of the Western Hemisphere. Ann. Rev Mcrobiol. 56,371–402 (2002).
   PubMed Web of Science ®Google Scholar
• •Comprehensive review of West Nile virus (WNV) molecular biology.
   Google Scholar
• Smithburn KC, Hughes TP, Burke AW etal A neurotropic virus isolated from the blood of a native of Uganda. Am. J Trop. Merl 20,471–492 (1940).
   Google Scholar
• Petersen LR, Roehrig JT. West Nile virus: a reemerging global pathogen. Emerg. Infect. Dis. 7,611–614 (2001).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Provisional surveillance summary of the West Nile virus epidemic: United States, January—November 2002. Morb. Mortal Wkly Rep. 51,1129-1133 (2002).
   Google Scholar
• Davis B, Chang G, Cropp B etal West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J Viral 75, 4040–4047 (2001).
   PubMed Web of Science ®Google Scholar
• ••Recombinant envelope and premembraneproteins of WNV secreted from a plasmid-transformed COS cell line can be used as antigens in ELISAs.
   Google Scholar
• Monath T Prospects for development of a vaccine against the West Nile virus. Ann. NY Acad. Sci. 951,1–12 (2001).
   Google Scholar
• Bernard 1KA, Maffei JG, Jones SA etal West Nile virus infection in birds and mosquitoes, New York State, 2000. Emerg. Infect. Dis. 7,679-685 (2001).
   Google Scholar
• Nasci R, White D, Stirling H etal West Nile virus isolates from mosquitoes in New York and New Jersey, 1999. Emerg. Infect. Dis. 7,626-630 (2001).
   Google Scholar
• Centers for Disease Control and Prevention. Guidelines for surveillance, prevention and control of West Nile virus infection — United States. Morb. Mortal. Wkly Rep. 49,25–28 (2000).
   PubMedGoogle Scholar
• Shi PY, Kramer LD. Molecular detection of West Nile virus RNA. Expert Rev Mal Diagn. 3, 357–366 (2003).
   PubMed Web of Science ®Google Scholar
• Shi PY, Kauffman EB, Ren P etal High-throughput detection of West Nile virus RNA. J Clin. Mcrobiol 39, 1264–1271 (2001).
   PubMed Web of Science ®Google Scholar
• Lanciotu RS, Kerst AJ, Nasci RS etal Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes and avian samples by a TaqMan reverse transcriptase-PCR assay. Clin. Nlicrobiol 38,4066–4071 (2000).
   PubMedGoogle Scholar
• Lanciotti R, Kerst A. Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J Clin. Mcrobiol 39, 4506–4513 (2001).
   PubMed Web of Science ®Google Scholar
• Briese T, Glass WG, Lipkin WI. Detection of West Nile virus sequences in cerebrospinal fluid. Lancet355, 1614–1615 (2000).
   Google Scholar
• Centers for Disease Control and Prevention. Update: investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion — Michigan, 2002. Morb. Mortal. Wkly Rep. 51,879 (2002).
   Google Scholar
• Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding — Michigan, 2002. Morb. Mortal. Wkly Rep. 51,877-878 (2002).
   Google Scholar
• Centers for Disease Control and Prevention. Intrauterine West Nile virus infection — New York, 2002. Morb. Mortal. Wkly Rep. 51,1135-1136 (2002).
   Google Scholar
• Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections — United States, 2002. Morb. Mortal Wkly Rep. 51,1133-1135 (2002).
   Google Scholar
• Heinz FX, Roehrig JT. Flaviviruses. In: Immunochemistry of Viruses. Elsevier, Amsterdam, The Netherlands, 289–305 (1990).
   Google Scholar
• Young PR, Hilditch PA, Bletchly C etal An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. j Clin. Mcrobiol 38, 1053–1057 (2000).
   Google Scholar
• Kuno G, Vorndam AV, Gubler DJ etal Study of antidengue NS1 antibody by western blot.J. Med Viral 32,102–108 (1990).
   Google Scholar
• Shu PY, Chen LK, Chang SF etal Potential application of nonstructural protein NS1 serotype-specific immunoglobulin G enzyme-linked immunosorbent assay in the seroepidemiologic study of dengue virus infection: correlation of results with those of the plaque reduction neutralization test. Clin. Mcrobiol 40,1840–1844 (2002).
   Google Scholar
• •Dengue nonstructural (NS) 1-basedELISA can be used to differentiate primary and secondary dengue infection and serotypes of primary dengue infection.
   Google Scholar
• Rothman AL, Kurane I, Lai CJ etal Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T-lymphocytes. j Viral. 67,801–806 (1993).
   PubMed Web of Science ®Google Scholar
• Hill AB, Lobigs M, Blanden RV etal The cellular immune response to flaviviruses. In: Viruses and the Cellular Immune Response. Thomas DB (Ed.), Marcel Dekker, NY, USA, 363–388 (1993).
   Google Scholar
• Wong S, Boyle R, Demarest V etal An immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and flavivirus vaccination. j Clin. Microbial. 41, 4217–4223 (2003).
   Google Scholar
• ••First report to use purified NS5 protein ofWNV as an antigen to perform virus type-specific serological diagnosis of flaviviruses.
   Google Scholar
• Tardei G, Ruta S, Chitu V etal Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection. Clin. Mcrobiol 38,2232–2239(2000).
   PubMed Web of Science ®Google Scholar
• Roehrig JT, Nash D, Malden B etal Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg. Infect. Dis. 9,376–379 (2003).
   PubMed Web of Science ®Google Scholar
• •Demonstrated that anti-WNV IgIVI in serum persists in many patients for 3–6 months after symptom onset and can extend beyond 15 months.
   Google Scholar
• Beaty BJ, Calisher CH, Shope RE. Diagnostic procedures for viral, rickettsial and chlamydial infections. Arboviruses 7, 204–205 (1995).
   Google Scholar
• Martin DA, Muth DA, Brown T etal Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. j Clin. Microbial. 38, 1823–1826 (2000).
   PubMed Web of Science ®Google Scholar
• •Evaluated and standardized a combined IgM antibody capture-ELISA to identify virus infections caused by arboviruses from three virus families: the Togaviridae, Flardviridae and Banyavkidae.
   Google Scholar
• Martin DA, Biggerstaff BJ, Allen B etal Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin. Diagn. Lab. Immunol 9,544–549 (2002).
   PubMedGoogle Scholar
• Roehrig JT, Mathews JH, Trent DW. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Vimlogy 128,118–126 (1983).
   Google Scholar
• Nash D, Mostashari F, Fine A et al The outbreak of West Nile virus infection in the New York City area in 1999. N Engl. Med 344,1807–1814 (2001).
   Google Scholar
• Johnson AJ, Langevin S, Wolff KL etal Detection of anti-West Nile virus immunoglobulin M in chicken serum by an enzyme-linked immunosorbent assay. Clin. Mcrobiol 41,2002–2007 (2003).
   PubMedGoogle Scholar
• Monath TP, Nystrom RR, Bailey RE et al Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis. j Clin. Mcrobiol 20,784–790 (1984).
   PubMedGoogle Scholar
• Lhullier M, Sarthou JL. Interet des IgM anti-amariles dans le diagnostic et la surveillance epidemiologique de la fievre jaune. Ann. Vim'. 134,349–359 (1983).
   Google Scholar
• Mortimer PR Antibody tests: progress and pitfalls. Clin. Diagn. Viral. 5,131–136 (1996).
   PubMedGoogle Scholar
• Johnson AJ, Martin DA, Karabatsos N etal Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. j Clin. Microbial. 38,1827–1831 (2000).
   PubMedGoogle Scholar
• Kaufman BM, Summers PL, Dubois DR etal Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am. j Trop. Med Hyg: 36,427-434 (1987).
   Google Scholar
• Gubler D, Campbell G, Nasci R etal West Nile virus in the United States: guidelines for detection, prevention and control. Viral Immunol 13,469–475 (2000).
   PubMedGoogle Scholar
• Ebel G, Dupuis A, Nicholas D etal Detection by enzyme-linked immunosorbent assay of antibodies to West Nile virus in birds. Emerg: Infect. Dis. 8,979–982 (2002).
   Google Scholar
• P1110t J. The year of Pasteur: from the concept of antibody and antigen by Bordet (1895) to the ELISA. What future for immunological diagnosis? Clin. Diagn. Viral. 5,191-196 (1996).
   Google Scholar
• Koraka P, Zeller H, Niedrig M etal Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Maybes Infect. 4,1209–1215 (2002).
   PubMed Web of Science ®Google Scholar
• Chen W-R, Rico-Hesse R, Tesh R. A new genotype of Japanese encephalitis virus from Indonesia. Am. j Trop. Med Hyg. 47, 61–69 (1992).
   PubMed Web of Science ®Google Scholar
• Casals J, Brown LV. Hemagglutination with anthropod-borne viruses. I Exp. Med 99, 429–449 (1954).
   PubMed Web of Science ®Google Scholar
• Weingartl HM, Drebot M, Hubakek Z etal Comparison of assays for the detection of West Nile virus antibodies in chicken serum. Can. j Vet. Res. 67, 128–132 (2003).
   PubMedGoogle Scholar
• Beaty BJ, Callisher CH, Shope RE. Arboviruses. In: Diagnostic Procedures for Viral, Rickettsia' and Chlamydial Infections, 7th Edition. Lennette EH, Lennette DH, Lenette ET (Eds), American Public Health Association, WA, USA (1995).
   Google Scholar
• Lindsey HS, Calisher CH, Mathews JH. Serum dilution neutralization test for California group virus identification and serology. j Clin. Mcrobiol 4,503–510 (1976).
   Google Scholar
• Kellar KL, Kalwar KA, Dubous IKA etal Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry45,27–36 (2001).
   PubMedGoogle Scholar
• •Describes multiplexed sandwich immunoassays for eight cytokines by coupling cytokine-specific capture antibodies to beads with different emission spectra.
   Google Scholar
• Mandy FF, Nakamaura T, Bergeron M et al Overview and application of suspension array technology. Gun. Lab. Med. 21, 713–729 (2001).
   Google Scholar
• Rappole J, Derrickson S, Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg. Infect. Dis. 6,319–328 (2000).
   Google Scholar
• Centers for Disease Control and Prevention. Update: surveillance for West Nile virus in overwintering mosquitoes: New York, 2000. Morb. Mortal. Wkly Rep. 49,178-179 (2000).
   Google Scholar
• Chamberlain R. History of St. Louis encephalitis. In: St. Louis Encephalitis. Monath TP (Ed.), American Public Health Association, WA, USA, 3–61 (1980).
   Google Scholar
• Huang C, Slater B, Campbell W et al Detection of arboviral RNA directly from mosquito homogenates by reverse-transcription-polymerase chain reaction. Vim. Methods94, 121–128 (2001).
   PubMedGoogle Scholar
• Johnson D, Ostlund E, Pedersen D etal Detection of North American West Nile virus in animal tissue by a reverse transcription-nested polymerase chain reaction assay. Emerg. Infect. Dis. 7, 739–741 (2001).
   PubMedGoogle Scholar
• Churdboonchart V, Bhamarapravati N, Peampramprecha S etal Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am. Trop. Med. Hyg. 44,481–493 (1991).
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Trent DW. Group B arbovirus structural and nonstructural antigens. Infect. Immunity8, 993–999 (1973).
   PubMedGoogle Scholar
• ••Demonstrated that NS proteins of dengue,St. Louis encephalitis or WNV react with only homologous sera but not with heterologous sera.
   Google Scholar
• Shu PY, Chen LK, Chang SF etal Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of MAb-based indirect ELISA to differentiate infection from vaccination. Vaccine 19,1753–1763 (2001).
   PubMed Web of Science ®Google Scholar
• Shu PY, Chen LK, Chang SF etal Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. j Med. Viral 62, 224–232 (2000).
   Google Scholar
• Blitvich BJ, Bowen RA, Marlenee NL, Hall RA, Bunning ML, Beaty BJ. Epitope-blocking enzyme-linked immunosorbent assays for detection of West Nile virus antibodies in domestic mammals. j Gun. Nlicrobiol 41,2676–2679 (2003).
   Google Scholar
• Centers for Disease Control and Prevention. Inactivated Japanese Encephalitis Virus Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal Wkly Rep. 42,1–15 (1993).
   PubMedGoogle Scholar
• Zinkernagel RM, LaMarre A, Ciurea A etal Neutralizing antiviral antibody responses. Adv. Immunol 79,1–53 (2001).
   PubMed Web of Science ®Google Scholar
• Brinton MA, Kurane I, Mathew A etal Immune mediated and inherited defenses against flaviviruses. Gun. Diagn. Vim. 10, 129–139 (1998).
   Google Scholar
• Crill WD, Roehrig JT. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. j Vim'. 75,7769–7773 (2001).
   Google Scholar
• Binley JM, Arshad H, Fouts TR, Moore JR An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus Type 1. AIDS Res. Hum. Retroviruses 13, 1007–1015 (1997).
   Google Scholar
• Thomas HI, Wilson S, O'Toole CM etal Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin. Exp. Immunol 103,185–191 (1996).
   Google Scholar
• Kayser M, Klein H, Paasch I, Pilaski J, Blenk H, Heeg K. Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine. j Med. Vim. 17,35-45 (1985). Affiliations
   Google Scholar